Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page
- ChecktodayChange DetectedFooter shows Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor UI/metadata update and does not affect the study content.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check36 days agoChange DetectedRemoved the government funding lapse notice about NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedNo significant changes detected in core study information between the two screenshots; any differences seem limited to formatting or minor layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check79 days agoChange DetectedCore page content updated to reflect current operating status and a new version (v3.2.0); previous version (v3.0.2) is removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.